Table 2
Invasive Cancer Incidence by Primary Site and Age at Diagnosis
Michigan Residents, 2019

Primary Site
  (ICD-O-3 Cancer Incidence
Site Groupings)
 
Total Less than 50 Years 50 - 74 Years 75 Years & Over
Number Age-
Adjusted
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Gastrointestinal Tract
& Digestive System
11,392 87.7 ±1.6 1,011 16.4 ±1.0 7,042 228.7 ±5.2 3,339 458.8 ±14.7
Lip, Oral Cavity & Pharynx 1,516 11.6 ±0.6 152 2.5 ±0.4 1,067 34.7 ±2.1 297 40.8 ±4.6
Stomach 709 5.4 ±0.4 50 0.8 ±0.2 426 13.8 ±1.3 233 32.0 ±4.1
Colon 3,212 25.4 ±0.9 351 5.7 ±0.6 1,742 56.6 ±2.6 1,119 153.7 ±8.8
Rectum 1,554 12.6 ±0.6 232 3.8 ±0.5 1,006 32.7 ±2.0 316 43.4 ±4.8
Pancreas 1,846 13.7 ±0.6 87 1.4 ±0.3 1,145 37.2 ±2.1 614 84.4 ±6.6
Other Gastrointestinal
Tract & Digestive System
2,555 18.9 ±0.7 139 2.2 ±0.4 1,656 53.8 ±2.6 760 104.4 ±7.3
Respiratory System &
Pleura
8,664 62.8 ±1.3 232 3.8 ±0.5 5,662 183.9 ±4.7 2,770 380.6 ±13.5
Larynx 437 3.1 ±0.3 24 0.4 ±0.2 338 11.0 ±1.2 75 10.3 ±2.3
Lung & Bronchus 8,130 58.9 ±1.2 194 3.1 ±0.4 5,271 171.2 ±4.5 2,665 366.2 ±13.3
Other Respiratory 97 0.8 ±0.2 14 *   53 1.7 ±0.5 30 4.1 ±1.5
Bones & Soft Tissue 414 3.7 ±0.4 143 2.3 ±0.4 173 5.6 ±0.8 98 13.5 ±2.7
Melanoma of Skin 2,411 19.6 ±0.8 437 7.1 ±0.7 1,374 44.6 ±2.3 600 82.4 ±6.5
Breast 8,151 66.0 ±1.5 1,352 21.9 ±1.2 5,107 165.9 ±4.5 1,692 232.5 ±10.8
Genitourinary Organs 16,264 120.3 ±1.8 1,172 19.0 ±1.1 11,323 367.7 ±6.5 3,769 517.8 ±15.5
Cervix Uteri 324 3.2 ±0.4 154 2.5 ±0.4 139 4.5 ±0.7 31 4.3 ±1.5
Corpus Uteri 1,905 14.4 ±0.7 192 3.1 ±0.4 1,402 45.5 ±2.4 311 42.7 ±4.7
Ovary 575 4.7 ±0.4 94 1.5 ±0.3 346 11.2 ±1.2 135 18.5 ±3.1
Prostate Gland 7,893 54.8 ±1.2 119 1.9 ±0.3 6,277 203.8 ±4.9 1,497 205.7 ±10.2
Other Genital 804 7.0 ±0.5 280 4.5 ±0.5 352 11.4 ±1.2 172 23.6 ±3.5
Urinary Bladder 2,585 19.1 ±0.7 64 1.0 ±0.2 1,417 46.0 ±2.4 1,104 151.7 ±8.8
Kidney and Renal Pelvis 2,024 16.0 ±0.7 268 4.3 ±0.5 1,304 42.3 ±2.3 452 62.1 ±5.7
Other Urinary 154 1.1 ±0.2 1 *   86 2.8 ±0.6 67 9.2 ±2.2
Brain & Other Central
Nervous System
681 5.8 ±0.4 182 2.9 ±0.4 361 11.7 ±1.2 138 19.0 ±3.2
Lymphomas 2,605 20.9 ±0.8 438 7.1 ±0.7 1,386 45.0 ±2.4 781 107.3 ±7.4
Hodgkin Lymphoma 238 2.3 ±0.3 143 2.3 ±0.4 71 2.3 ±0.5 24 3.3 ±1.3
Non-Hodgkin Lymphoma 2,367 18.6 ±0.8 295 4.8 ±0.5 1,315 42.7 ±2.3 757 104.0 ±7.3
Multiple Myeloma 825 6.2 ±0.4 49 0.8 ±0.2 484 15.7 ±1.4 292 40.1 ±4.6
Leukemias 1,698 13.4 ±0.6 232 3.8 ±0.5 919 29.8 ±1.9 547 75.2 ±6.2
All Other 3,500 29.1 ±1.0 757 12.2 ±0.9 1,697 55.1 ±2.6 1,046 143.7 ±8.6
Total 56,605 435.5 ±3.5 6,005 97.2 ±2.4 35,528 1,153.8 ±10.4 15,072 2,070.8 ±25.4
               

Notes: Age-Specific Rates are per 100,000 population in a specific age group. Age-Adjusted Rates are per 100,000 population. Age-adjusted rates are computed by the direct method, using as the standard population the age distribution of the total population of the United States for the year 2000. Adding and subtracting the number shown after the ± symbol from the rate creates a confidence interval indicating that the true rate lies between the lower and upper bounds of this interval with 95 % statistical confidence.
Case : A case is defined as a person with any newly diagnosed cancer with a behavior code of 3 (malignant primary site). Both in-situ and invasive urinary bladder cancer cases are included, in order to be consistent with SEER tabulations from the National Cancer Institute.
* : A rate is not calculated when there are fewer than 20 total events, or fewer than 6 events in an age category, because the width of the confidence interval would negate any usefulness for comparative purposes.
Source: Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2021. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services.
Last Updated: April 20, 2022